Protein Binding of Drugs.

 

  • A drug in the body can interact with several tissue components of which the two major categories are blood and extravascular tissues. 

  • The interacting molecules are generally the macromolecules such as

  • proteins, DNS and adipose tissue.

  •  The phenomenon of complex formation of drugs with protein is called protein binding.

  •  As a protein-bound drug is neither metabolized or excreted, it is pharmacologically inactive.

  •  Protein + drug ⇌Protein-drug complex

  • Protein binding may be divided into:

    • 1. Intracellular binding.

    • 2. Extracellular binding.

MECHANISMS OF PROTEIN DRUG BINDING.

  • Binding of drugs to proteins is generally reversible & irreversible.

  • Reversible generally involves weak chemical bonds such as:

    • 1. Hydrogen bonds

    • 2. Hydrophobic bonds

    • 3. Ionic bonds

    • 4. Van der waals forces.

  • Irreversible drug binding, though rare, arises as a result of covalent binding and is often a reason for the carcinogenicity or tissue toxicity of the drug.

  1. BINDING OF DRUG TO BLOOD COMPONENTS:

A. Plasma protein-drug binding:-

  • The binding of drugs to plasma proteins is reversible.

  • The extent or order of binding of drug to plasma proteins is:

    • Albumin ›ὰ1-Acid glycoprotein ›Lipoproteins ›Globulins.

  • 1. Binding of drug to Human Serum Albumin (HSA):

    • Most abundant plasma protein (59%), 

    • M.W.: 65,000 

    • Large drug binding capacity.

    • Both endogenous compounds such as fatty acid, bilirubin as well as drugs bind to HSA.

    • Four different sites on HSA for drug binding.

      • Site I: warfarin & azapropazone binding site.

      • Site II: diazepam binding site.

      • Site III: digitoxin binding site.

      • Site IV: tamoxifen binding site.

  • 2. Binding of drug to α1-Acid glycoprotein: 

    • α1-Acid glycoprotein is als called “Orosomucoid”.

    • Plasma conc. range of 0.04 to 0.1 g%.

    • M.W. 44,000.

    • Binds to no. of basic drugs like imipramine, lidocaine, propranolol,n quinidine etc.

  • 3. Binding of drug to Lipoproteins:

    • Four types,

      • Chylomicrons.

      • Verl Low Density Lipoproteins (VLDL).

      • Low Density Lipoproteins (LDL).

      • High Density Lipoproteins (HDL).

    • Binding by: Hydrophobic Bonds, 

    • Non-competitive.

    • Mol wt: 2 L -34 L dalton.

    • Lipid core composed of:

      • Inside: triglyceride & cholesteryl esters.

      • Outside:Apoprotein.

    • E.g of drugs: 

      • Acidic: Diclofenac.

      • Neutral: CyclosporinA.

      • Basic: Chlorpromazine.

  • 4. Binding of Drugs to Globulines:

    •  Globulines are mainly used for transportation of internal substances; however, certain drugs also bind with them.

    • They are of the following types,

      • 𝞪 Globulines 1.

      • 𝞪 Globulines 2.

      • 𝞫 Globulines 1.

      • 𝞫 Globulines 2.

      • 𝜸 Globulines.

    • 𝞪 Globulines 1 are also called Corticoplasmins, they transfer corticosteroids, certain drugs like Hydrocortisone and Prednisolone are known to bind with them.

    • 𝞪 Globulines 2 are also called Ceruloplasmins, they transfer Fat Soluble vitamins like Vit. A, D, E, K.

    • 𝞫 Globulines 1 are called Transferrin and are involved in transport of Iron.

    • 𝞫 Globulines 2 are involved in transport of carotenoids.

    • 𝜸 Globulines are mainly involved in Antigen Antibody reaction and are now a days explored for Antiviral actions.

B. BINDING OF DRUG TO BLOOD CELLS:

  • Blood contains 40% of blood cells of which the major component is RBC (95%)

  • The RBC is 500 times in diameter as the albumin.

  • The rate & extent of entry into RBC is more for lipophilic drugs.

  • The RBC comprises 3 components

    • a) Hemoglobin: It has a M.W. of 64,500 Dal. Drugs like phenytoin, pentobarbitone bind to hemoglobin.

    • b) Carbonic anhydrase: Carbonic anhydrase inhibitors drugs are bound to it like acetazolamide & chlorthalidone.

    • c) Cell membrane: Basic drugs like Imipramine & chlorpromazine are reported to bind with the RBC membrane.

  1. BINDING OF DRUG TO EXTRAVASCULAR TISSUE PROTEINS.

  • Rare phenomenon.

  • Usually irreversible and is the result of toxicity of the drugs.

  • Drugs showing higher binding to extracellular proteins have a higher apparent volume of distribution.

  • There is no competition for binding sites.

  • Factors affecting: lipophilicity, structural feature of drug, perfusion rate, pH differences.

  • Binding order: Liver › Kidney › Lung › Muscles.

    • Liver: Metabolites of Chloroform And Paracetamol bind with liver components causing toxicity.

    • Lungs: Basic drugs accumulate in lungs e.g. Imipramine, propranolol, Antihistamines etc.

    • Kidney: Heavy metals bind with Metallothionein protein in the kidney causing nephrotoxicity.

    •  Skin and Eye: Chloroquine and Phenothiazines bind with melanin.

    • Hairs: Arsenic, Chloroquine and Phenothiazines.

    • Bones: Tetracyclines.

Topics u may like to read